Skip to main content

New York's Overdose Deaths Hit a Six-Year Low. The Crack-Era Generation Is Still Dying at Home.

The city's numbers are real and worth celebrating. Inside them is a generation of Black and Latino men in their late 50s and 60s, using alone, for whom the decline barely arrived.

ByThe Rize NewsroomNovember 14, 202611 min readFentanyl

Ricky Austin started using heroin as a teenager in East Baltimore. By the time he was around 50, he had nearly died of an overdose three times. When the Philadelphia Inquirer found him in late 2024, he was 52, living in a South Philadelphia recovery home, working food service at the University of Pennsylvania, and on methadone. He told reporters what people his age in recovery say so often it no longer sounds like news: “All the guys I got high with — they’re all gone. They’re all dead.” He was not exaggerating. He was doing arithmetic.

Hold that sentence next to the good news New York City announced on Friday. Mayor Zohran Mamdani said the city recorded 359 overdose deaths between April and June of this year, the lowest three-month total since 2019 and well under half the record 859 deaths of late 2022. For all of 2025, the Health Department counts 1,873 overdose deaths, down 39% from the 2022 peak. That is roughly 1,200 fewer funerals than in 2022. But read the city’s own data brief and a second story sits in the tables. It is Ricky Austin’s.

New York’s overdose decline is real. It is also skipping the men the last drug war was written for.

The decline is a citywide average, and averages hide who is still dying

Start with what the Health Department itself put in writing. Overdose death rates among white New Yorkers have returned to pre-pandemic levels; rates among Black and Latino New Yorkers have not. In 2025, Black New Yorkers died of overdose at 37.3 per 100,000 and Latino New Yorkers at 35.8, about twice the white rate of 18.1. The single highest-risk group in the city is Black New Yorkers aged 55 to 64, at 88.2 deaths per 100,000. That number fell 28% from the year before, which is genuine progress, and it is still more than three times the citywide rate. If you are a Black man in your late fifties in the South Bronx, the “lowest since 2019” headline describes a city you only partly live in.

Then look at age. Between 2024 and 2025, overdose death rates fell for every age group in New York except one. New Yorkers aged 65 to 84 went the other direction, up 5%, from 26.0 to 27.3 per 100,000. The oldest people using drugs in the city are the only ones whose risk is rising. That is not a statistical quirk; it is a cohort aging into the danger zone. The Bronx, meanwhile, still buries its residents at 51.0 per 100,000, more than twice the rate of any other borough, and the latest quarterly map shows the highest neighborhood rates clustered in the Bronx, Upper Manhattan, Central Brooklyn and north Staten Island.

None of this is unique to New York, which is what makes it a pattern instead of a local footnote. A national analysis of CDC death records by Zongbo Li, Xiao Zang and colleagues, published this year in Drug and Alcohol Dependence Reports, found that since 2015 overdose deaths among Black adults 55 and older rose faster than among any other age or racial group, and by 2019 this group had the highest overdose death rate in the country. NIDA director Nora Volkow had flagged the same thing two years earlier, writing that NIDA’s own analysis found a nearly fivefold increase in overdose deaths among Black men 55 and older between 2015 and 2023. The New York data brief is the local edition of a national obituary page.

This is where a citywide number becomes dangerous in a quiet way. City budgets, grant applications, and press releases all run on the topline. When the topline falls 39%, the pressure is to declare the model working and hold it steady. But the model is working unevenly, and the people it is reaching least are the ones least likely to show up in a meeting about it. You can read more of our ongoing coverage of the numbers behind the overdose crisis, including why even the experts are still arguing over why deaths fell at all.

When the topline falls 39%, the pressure is to declare the model working and hold it steady.

We wrote the sentence for this generation in 1986

The men dying at 88 per 100,000 in New York were born between roughly 1961 and 1970. They were teenagers and young men when crack arrived, and they were the people Congress had in mind when it legislated against it. In June 1986, University of Maryland basketball star Len Bias died of a cocaine overdose two days after being drafted by the Boston Celtics. Four months later, Congress passed the Anti-Drug Abuse Act of 1986, which set mandatory minimums that treated five grams of crack the same as 500 grams of powder cocaine. The 100-to-1 ratio fell hardest on young Black men in exactly the neighborhoods that now top the overdose maps. It stood for 24 years, until the Fair Sentencing Act of 2010 cut it to 18-to-1 rather than erasing it. A generation went through prison and came out with records, gaps in work history, and a hard-won lesson that drug use is something you do where nobody can see you.

Katherine McLean, a sociologist at Penn State Greater Allegheny, put it precisely to PublicSource in Pittsburgh: this generation was “constructed [by policymakers] as the criminal drug user during the 1980s.” What was done to them then is shaping how they die now. Philadelphia City Councilmember Kendra Brooks, whose father used crack for most of her life, described the result to the Inquirer after learning of nine overdose deaths within about five square blocks of her neighborhood, all Black residents, most in their 50s or older: “In this generation, you don’t get high in public. It’s something very private and personal.” And then the line that should be on the wall of every health department: “Amongst folks that I know, it’s like a secret disease.”

New York’s data shows exactly what a secret disease looks like in a spreadsheet. In 2025, 71% of the city’s overdose deaths happened in a private home or supportive housing, and only 18% in public indoor, outdoor, or transit settings. People are not dying on the street corners that dominate the political fight over drug use. They are dying behind their own doors, often alone. Volkow’s blog named the same mechanism: loneliness and social isolation are well-known risk factors, and older people who lived alone and felt lonely had the highest rates of nonmedical drug use. Men lose partners and friends as they age. A man who has buried the guys he used with, as Austin has, has also buried the people who would have been in the room with naloxone.

That is the pattern repeating. In 1986 the country decided that the visible, public, young version of this generation was the problem and built a punishment apparatus around it. In 2026 the city’s political energy is still pointed at visibility, at who uses where and who can see it, while the same men, now in their sixties, are dying in the one place no outreach van drives past: their living room.

The fight over two Manhattan sites is real, and it is not where most of the dying happens

Nothing here is an argument against New York’s overdose prevention centers. OnPoint NYC’s two supervised sites in East Harlem and Washington Heights have intervened in more than 2,100 overdoses with no fatalities, according to the organization’s count reported by CBS News, across more than 7,000 registered participants and about 250,000 visits since 2021. They lost more than $2 million in federal SAMHSA grants after the July 2025 executive order barring federal money for supervised consumption, and they kept the doors open anyway. Pia Marcus, OnPoint’s director of overdose prevention, described what they offer in a sentence anyone who has used in a stairwell will recognize: “In an OPC, you don’t have to hide, you don’t have to rush, and you don’t have to feel shame.” That is exactly right, and it is exactly the experience this generation has been trained, by law and by funerals, to never expect.

But the honest reading of the city’s data is that the most-argued-about intervention in New York sits in public space, while 71% of deaths happen in private space. Two sites in Upper Manhattan cannot reach a 62-year-old in a Bronx apartment who would rather die than be seen walking into one, and the NIH-funded evaluation of the sites has not yet drawn conclusions about citywide mortality. Mamdani has praised OnPoint publicly. Whether he opens more sites is a real question worth fighting about. It is not the whole question.

Whether he opens more sites is a real question worth fighting about.

The drug itself is shifting under this generation too. Fentanyl is still involved in two out of three New York overdose deaths, down from 82% in 2022, but cocaine now shows up in 61% of fatal overdoses, and the share has risen every year since 2022. The number that should stop every clinician cold: overdose deaths involving cocaine with no opioid at all rose from 185 in 2022 to 308 in 2025. The national WONDER analysis found the same rise in cocaine-only deaths among older Black adults across every census region, and suggested “heightened age-related vulnerability” as a reason. In plain terms: a 60-year-old heart handles the same line of cocaine worse than a 25-year-old heart did, and decades of use, high blood pressure, and untreated illness stack the odds further. Naloxone reverses opioids. It does nothing for a cocaine-driven heart attack or stroke, which is why someone being in the room matters even more than the kit.

Add the sedatives now cut into the opioid supply, xylazine in 29% of opioid-involved deaths and medetomidine in 13%, and the picture for a man who has used cocaine for forty years and occasionally gets a bag that is not what he was told is a supply that changed under his feet. Albert Knight Jr., a 47-year-old in Philadelphia who had used cocaine since his twenties, told the Inquirer he did not know fentanyl had gotten into his drugs until his girlfriend died of an overdose. “I was clueless,” he said. We have written about the pull between using alone because it feels safer and using alone because it is how people die; for this generation, the cocaine line on the chart and the “private home” line are the same line. More on the drug itself lives on our cocaine pillar and our fentanyl pillar.

What reaching a secret disease actually takes

If you are the person this article is about, or you are married to him, or he is your uncle, here is what is still yours tonight. Naloxone is free in New York City through registered opioid overdose prevention programs, and sold over the counter for under $50 for two doses, with state coverage of copays up to $40; the city lists sites at nyc.gov/naloxone. If you use alone, the Never Use Alone line at 800-484-3731 will stay on the phone with you and send emergency help to your address if you stop responding. And if you use cocaine and have never touched an opioid, carry the naloxone anyway, because you do not control what is in the bag. None of that is a lecture. It is the list of doors that are still open.

For providers, the move this week is concrete. Screen every patient over 50 for cocaine use directly, not as a follow-up to an opioid question, and hand naloxone to every one of them who says yes. Add “Do you usually use alone, at home?” to intake, because in New York that question now describes seven out of ten deaths. Primary care clinics, senior centers and dialysis units see this generation far more often than any harm reduction program does; a standing naloxone order at the front desk of a geriatric practice reaches people a syringe service van will never meet. Mamdani’s office says the city is putting $12 million into recovery services and 500 new peer specialist positions over four years. Hire some of those peers from this generation and send them to knock on doors in the South Bronx. Chuck Davis, a 71-year-old former steelworker in long-term recovery, regularly reverses overdoses in Pittsburgh’s Hill District as a case manager. That is the model. The messenger is the intervention.

Mamdani’s office says the city is putting $12 million into recovery services and 500 new peer specialist positions over four years.

Chief Medical Examiner Jason Graham called the city “cautiously optimistic” on Friday, and that is the right register. The decline is a real thing that people did: naloxone in every borough, treatment that got easier to start, peers who refused to quit. It deserves a press release.

But a city can bend its curve while a generation’s curve stays flat, and New York has now documented, in its own words, that this is happening. Ricky Austin survived because, as he put it, “somebody was there for me.” Every guy he got high with died because, at the moment it mattered, nobody was. The next 39% will not come from louder arguments about street corners. It will come from finding a way into the room where a 60-year-old man is using alone, and making sure that when he goes down, somebody is there.

Filed Under

trendssocial-culturalharm-reductionFentanylCocainePolysubstanceOverdoseNaloxoneGovernment DataPeer SupportStigma

Keep up with the reporting.

One email each morning with the stories that put days like this in context.

A daily, no-spam briefing. Unsubscribe anytime.

Continue reading

More from this section